Morning administration of 0.4 U/kg/day insulin glargine 300 U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100 U/mL in type 1 diabetes
Bailey, T.S., Pettus, J., Roussel, R., Schmider, W., Maroccia, M., Nassr, N., Klein, O., Bolli, G.B., Dahmen, R.Language:
english
Journal:
Diabetes & Metabolism
DOI:
10.1016/j.diabet.2017.10.001
Date:
November, 2017
File:
PDF, 770 KB
english, 2017